在常规诊疗中验证银屑病关节炎患者对指炎、银屑病皮肤与甲病变及葡萄膜炎的患者报告结局测量工具
在丹麦DANBIO注册系统的常规诊疗中,对300例银屑病关节炎患者实施针对指炎、皮肤与甲银屑病及近期葡萄膜炎的患者报告结局测量工具(PROM),以医生评估为金标准进行横断面验证。结果显示各PROM的敏感度/特异度分别为指炎0.89/0.81、银屑病1.0/0.94、甲银屑病0.76/0.94、葡萄膜炎1.00/0.99,患者报告的指炎计数平均比医生高1.0个单位,加入指炎照片后降至0.7。结论认为患者能可靠自报指炎、银屑病和葡萄膜炎,PROM对常规监测非肌肉骨骼表现有价值。
要点
- 指炎PROM敏感度0.89、特异度0.81、Cohen kappa 0.57;银屑病PROM为1.0/0.94/0.95;甲银屑病为0.76/0.94/0.66;葡萄膜炎为1.00/0.99/0.59。
- 患者报告的指炎计数平均比医生报告高1.0个单位,加入指炎照片后差异降至0.7个单位。
- 银屑病范围同意率为90%,结果在设盲与否情况下相似。
核心结论
- 患者能可靠自报指炎、银屑病和葡萄膜炎,PROM对常规诊疗中监测非肌肉骨骼表现有价值。
研究设计与样本
- 自适应横断面研究,纳入300例银屑病关节炎患者,中位年龄55岁,51%为女性,中位病程8年,43%接受生物制剂治疗。
- 患者在DANBIO中回答PROM(是/否/不知道)并评估皮肤银屑病范围和指炎受累指计数。
- 以医生评估(体格检查、查阅患者档案)为金标准,从第200例患者起医生对PROs设盲。
主要发现
- 根据医生评估,41例(14%)有当前指炎,164例(55%)有银屑病,163例(54%)有甲银屑病,3例(1%)有近期葡萄膜炎。
- 指炎PROM的敏感度/特异度/Cohen kappa为0.89/0.81/0.57,银屑病为1.0/0.94/0.95,甲银屑病为0.76/0.94/0.66,葡萄膜炎为1.00/0.99/0.59。
- 银屑病范围同意率为90%。
- 患者报告的指炎计数平均比医生报告高1.0个单位,加入指炎照片后降至0.7。
- 设盲与否结果相似。
关键数值与推荐
- 指炎PROM:敏感度0.89,特异度0.81,Cohen kappa 0.57。
- 银屑病PROM:敏感度1.0,特异度0.94,Cohen kappa 0.95。
- 甲银屑病PROM:敏感度0.76,特异度0.94,Cohen kappa 0.66。
- 葡萄膜炎PROM:敏感度1.00,特异度0.99,Cohen kappa 0.59。
- 银屑病范围同意率90%;指炎计数患者报告平均比医生高1.0个单位,加照片后高0.7个单位。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In routine care, Danish patients with psoriatic arthritis are monitored in the DANBIO registry. In March 2022, patient-reported outcome measures (PROMs) on selected non-musculoskeletal manifestations (NMM) were implemented. AIM: To validate PROMs for current dactylitis, skin and nail psoriasis, and recent uveitis in patients with psoriatic arthritis. METHODS: Adaptive cross-sectional study. Patients in the rheumatologic clinic answered PROMs with 'yes'/'no'/'do not know' and assessed the extent of skin psoriasis and number of dactylitis-affected digits in DANBIO. PROM entries were compared with the physician's assessments (physical examination, review of patient file), with the physician being the gold standard. With 134 patients included, 20% had incorrectly reported dactylitis; therefore, a dactylitis photo was added to the PROM. Sensitivity, specificity, positive and negative predictive values, accuracy and Cohen's kappa were calculated. Level of agreement for dactylitis count was explored by Bland-Altman plot. From patient 200, the physician was blinded to PROs. RESULTS: We included 300 patients (51% female, median age=55 years), with a median disease duration of 8 years, where 43% received biologic treatment. According to the physician's assessment, 41 (14%) patients had current dactylitis, 164 (55%) psoriasis, 163 (54%) nail psoriasis and 3 (1%) recent uveitis. For the dactylitis PROM, the sensitivity/specificity/Cohen's kappa was 0.89/0.81/0.57, psoriasis 1.0/0.94/0.95, nail psoriasis 0.76/0.94/0.66 and uveitis 1.00/0.99/0.59. Agreement on psoriasis extent was 90%. Patient-reported dactylitis count was on average 1.0 unit higher than physician-reported but decreased to 0.7 after adding the dactylitis photo. Results were similar irrespective of blinding. CONCLUSION: Patients reliably self-report dactylitis, psoriasis, and uveitis and the PROMs are valuable for monitoring NMMs in routine care.
引用
- Nielung LM, Dreyer L, Skov L, et al. Validation of patient-reported outcome measures for dactylitis, psoriatic skin and nail disease, and uveitis in patients with psoriatic arthritis in routine care. RMD Open. 2025. PMID: 40617585. doi:10.1136/rmdopen-2025-005705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。